The Discovery of the MCH-1 Receptor Antagonist NGD-4715 for the Potential Treatment of Obesity
2017
The authors of this article were previously employed by Neurogen Corporation, a subsidiary of Ligand Pharmaceuticals.
- Correction
- Source
- Cite
- Save
- Machine Reading By IdeaReader
34
References
1
Citations
NaN
KQI